Article

A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts…

medRxiv · 2022 · Avanzato, V. A.; Bushmaker, T.; Oguntuyo, K. Y.; Yinda, K. C.; Duyvesteyn, H. M. E.; Stass, R.; Meade-White, K.; Rosenke, R.; Thomas, T.; Saturday, G.; Doores, K. J.; Lee, B.; Bowden, T.; Munster, V.

Key facts

Title A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease
First author Avanzato, V. A.; Bushmaker, T.; Oguntuyo, K. Y.; Yinda, K. C.; Duyvesteyn, H. M. E.; Stass, R.; Meade-White, K.; Rosenke, R.; Thomas, T.; Saturday, G.; Doores, K. J.; Lee, B.; Bowden, T.; Munster, V.
Journal medRxiv
Published Sep 29, 2022
DOI 10.1101/2022.09.26.507980
Devices mentioned K042152, K800781, K940422, K982100
Product codes mentioned CFN, DFZ, KIS, JJH, MVU

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature